Duravest, Inc. Completes Acquisition Of Bio-Magnetic Therapy Systems, Inc., An Emerging Medical Technology Company With Strong Earnings Growth

Duravest, Inc. (OTC BB:DUVT, XETRA:DUV) has completed the acquisition of Bio-Magnetic Therapy Systems, Inc. (BMTS) through two capital increases in combination with a tender offer to all BMTS shareholders. Duravest has acquired a minimum stake of 70.59% - at a total cost of US$ 5,448,466 - which represents a controlling position in the company. In order to facilitate this highly accretive transaction, Duravest obtained convertible financing. BMTS is a leading German-US medical technology firm dedicated to the safe, non-invasive treatment of osteoarthritis, osteoporosis and orthopedic injuries and its associated pain management. The company produces an innovative and patented “Pulsed Signal Therapy” (PSTT) system which delivers a unique pulsed electromagnetic signal that has been clinically shown to stimulate the healing of connective tissue (cartilage, tendons, ligaments and bone) injuries. The PSTT system has been extensively validated by more than 25 clinical studies and 60 peer reviewed publications worldwide; in addition, 51 international patents cover all the essential technical innovations as well as current and future treatment indications. More than 300,000 patients have been treated with a documented clinical success rate over 75%.

MORE ON THIS TOPIC